Almost Final Deal: 10 Marla Plot Up for Sale in DHA Phase 3 Islamabad

Prime Investment Opportunity: 10 Marla Plot in DHA Phase 3, Islamabad

Secure your stake in DHA Phase 3 Islamabad with this exceptional 10 Marla plot. Offered as a direct deal, this property presents a prime investment block with standard dimensions, ideal for discerning investors seeking substantial capital appreciation. DHA Phase 3 is strategically positioned for growth, benefiting from ongoing development and its proximity to key infrastructure, making it a highly recommended asset.

Quick Overview

• Property Type: Plot
• Size: 10 Marla
• Location: DHA Phase 3, Islamabad
• Street: 118
• Features: Direct Deal, Standard Dimensions, Prime Investment Block
• Demand: PKR 1.85 Crore

Plot Details

This 10 Marla plot is situated in Street 118 of DHA Phase 3, a rapidly developing sector known for its strategic planning and investment potential. The ‘Direct Deal’ status ensures a streamlined transaction process, while the ‘Standard Dimensions’ provide flexibility for future construction or resale. As a ‘Prime Investment Block’, this plot is positioned to capitalize on the ongoing development and infrastructure enhancements within DHA Phase 3, including its proximity to the Rawat T-Chowk and the planned Rawalpindi Ring Road.

Key Benefits for Investors

DHA Phase 3 represents a compelling investment sweet spot, offering the security of a DHA development with significant capital appreciation potential. The active development, including heavy earthwork and ongoing construction, signals rapid progress and imminent returns. Plots in this phase are considered highly liquid, making them attractive for investors looking for timely exits or future home construction. The pricing remains competitive compared to more established phases, presenting a lucrative entry point for smart investors.

Investment Value Proposition: This 10 Marla plot in DHA Phase 3 is a strategically sound acquisition, promising robust capital growth and a secure addition to any investment portfolio.